# Thyroid Function Tests in Ankylosing Spondylitis Patients on Anti-Tumour Necrosis Factor Treatment

## Authors

- Betul Sargin ([ORCID](https://orcid.org/0000-0002-9463-8413)) — Medical Faculty of Adnan Menderes University, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Aydın, Turkey
- Gulcan Gurer ([ORCID](https://orcid.org/0000-0001-8287-2264)) — Medical Faculty of Adnan Menderes University, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Aydın, Turkey

## Article information

- **Journal:** The Ulutas Medical Journal (Ulutas Med J), ISSN 2149-388X
- **Issue:** Volume 6, Issue 2 (2020), pages 53–58
- **Article type:** Original Article
- **Published online:** 2020-06-19
- **DOI:** [10.5455/umj.20200212024921](https://doi.org/10.5455/umj.20200212024921)
- **Licence:** [CC BY-NC 4.0](https://creativecommons.org/licenses/by-nc/4.0/)
- **Article page:** https://www.ulutasmedicaljournal.com/?mno=86786
- **PDF:** https://www.ulutasmedicaljournal.com/pdf/86786.pdf

## Abstract

Introduction: Ankylosing spondylitis (AS) is a chronic inflammatory disease. Thyroid dysfunctions are more frequent in patients with inflammatory diseases. In this study, we aimed to evaluate thyroid functions and thyroid autoantibodies in ankylosing spondylitis patients, to determine the effect of anti-tumor necrosis factor treatment in AS patients and the relationship between thyroid function and autoantibody levels, inflammatory markers and disease activity in ankylosing spondylitis patients. Materials and Methods: 74 ankylosing spondylitis patients diagnosed according to 1984 Modified New York criteria and Assessment in Spondylarthritis International Society classification criteria were included. 41 of them were receiving anti-tumor necrosis factor treatment and 33 of them were receiving nonsteroid anti-inflammatory drugs. We recorded patients' age, gender, erythrocyte sedimentation rates, C-reactive protein values, blood count, biochemical analysis, thyroid function tests, autoantibody levels, Bath Ankylosing Spondylitis Disease Activity Index. Results: Mean anti-thyroid peroxidase levels were significant at a high level in ankylosing spondylitis patients receiving anti-tumour necrosis factor compared to patients receiving nonsteroid anti-inflammatory drugs (p= 0.009).Negative correlation was found between thyrotropin-stimulating hormone and C-reactive protein(r=-0,264, p=0,023).A positive correlation was found between free thyroxine and C-reactive protein (r=0,436,p=0,009), anti-thyroid peroxidase positivity and erythrocyte sedimentation rate (r=0,384,p=0,001),anti-thyroglobulin positivity and erythrocyte sedimentation rates and C-reactive protein(r=0,329,r=0,265,p=0,004,p=0,022). Conclusion: The frequency of thyroid disorder in patients with AS receiving anti-TNF α was lower compared to patients receiving nonsteroid anti-inflammatory drugs. We can consider that anti-TNF α treatment could reduce autoimmune thyroid diseases and had a positive effect on thyroid functions.

## Keywords

Thyroid function; ankylosing spondylitis; anti-tumor necrosis factor treatment

## How to cite

Sargin B, Gurer G. Thyroid Function Tests in Ankylosing Spondylitis Patients on Anti-Tumour Necrosis Factor Treatment. Ulutas Med J. 2020;6(2):53-58. doi:10.5455/umj.20200212024921

## References

1. Moreno M, Gratacós J, Torrente-Segarra V, Sanmarti R, Morlà R, Pontes C, Llop M, Juanola X; REMINEA study Group. Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission results from the REMINEA study.Arthritis Res Ther. 2019;2:88 https://doi.org/10.1186/s13075-019-1873-3
2. Van der Linden S, Valkenburg HA, Cats A.Evaluation of diagnostic criteria for ankylosing spondylitis.A proposal for modification of the New York criteria.Arthritis Rheum. 1984; 27: 361-8 https://doi.org/10.1002/art.1780270401
3. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al.The development of Assessment of Spondylo Arthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis.2009;68:777-83 https://doi.org/10.1136/ard.2009.108233
4. Akbaryan M, Soltani Z.Overlap of Ankylosing Spondylitis and Systemic Lupus Erythematosus: A case report.International Journal of Medical Research & Health Sciences, 2016;4:100-3
5. Ye C, Li W.Cutaneous vasculitis in a patient with ankylosing spondylitis: A case report.Medicine (Baltimore).2019;98:e14121 https://doi.org/10.1097/md.0000000000014121
6. Ferdoutsis M, Bouros D, Meletis G, Patsourakis G, Siafakas NM. Diffuse interstitial lung disease as an early manifestation of ankylosing spondylitis. Respiration.1995;62:286-9
7. El Ouazzani FZ, Tahiri L, Akasbi N, Kadi N, Harzy T. Sarcoidosis and ankylosing spondylitis: a rare association. Pan Afr Med J.2011;8:23
8. Fominykh V, Shevtsova T, Arzumanian N, Brylev L. Coexistence of multiple sclerosis and ankylosing spondylitis: report of four cases from Russia and review of the literature. J Clin Neurosci.2017;44:230-3 https://doi.org/10.1016/j.jocn.2017.06.031
9. Katalin KE, István B, Enikő G, Julianna BA.Primary Biliary Cirrhosis and Ankylosing Spondylitis, A Rare Association. Internal Medicine.2018;6:43-9
10. Carbone M, Neuberger JM.Autoimmune liver disease, autoimmunity, and liver transplantation.Journal of Hepatology. 2014;60:210-23 https://doi.org/10.1016/j.jhep.2013.09.020
11. Robazzi TC, Adan LF. Autoimmune thyroid disease in patients with rheumatic diseases.Rev Bras Reumatol.2012;52:417-30
12. Lazúrová I, Jochmanová I, Benhatchi K, Sotak S.Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics. Immunol Res.2014;60:193-200 https://doi.org/10.1007/s12026-014-8598-9
13. Appenzeller S, Pallone AT, Natalin RA, Costallat LT. Prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumatol. 2009;15:117-9 https://doi.org/10.1097/rhu.0b013e31819dbe4c
14. Sun X, Lu L, Li Y, Yang R, Shan L, Wang Y. Increased risk of thyroid disease in patients with Sjogren's syndrome: a systematic review and meta-analysis.PeerJ.2019;7:e6737 https://doi.org/10.7717/peerj.6737
15. Lange U, Boss B, Teichmann J, Klett R, Stracke H, Bretzel RG, et al.Thyroid disorders in female patients with ankylosing spondylitis.Eur J Med Res. 1999;4:468-74
16. J Braun, J Davis, M Dougados, J Sieper, S van der Linden, D van der Heijde. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.Ann Rheum Dis 65:316-20 https://doi.org/10.1136/ard.2005.040758
17. Altan L, Sivrioğlu Y, Ercan İ. Can Bath Ankylosing Spondylitis Disease Activity Index be Affected by Accompanying Fibromyalgia or Depression? Arch Rheumatol. 2015; 30:34-9
18. Singh AS, Atam V, Yathish BE, Das L, Koonwar S. Role of erythrocyte sedimentation rate in ischemic stroke as an inflammatory marker of carotid atherosclerosis.J Neurosci Rural Pract. 2014;5:40-5 https://doi.org/10.4103/0976-3147.127870
19. Kim JM, Park DS. Evaluation of analytical measurement ranges of three full-range C-reactive protein tests using immunoturbidimetric assay. Korean J Lab Med. 2010; 30:9-16
20. Shim C, Chong R, Lee JH. Enzyme-free chemiluminescence immunoassay for the determination of thyroid-stimulating hormone.Talanta.2017 15;171:229-35 https://doi.org/10.1016/j.talanta.2017.05.007
21. Sriphrapradang C, Bhasipol A.Differentiating Graves' disease from subacute thyroiditis using the ratio of serum-free triiodothyronine to free thyroxine. Annals of Medicine and Surgery. 2016;10:69-72 https://doi.org/10.1016/j.amsu.2016.07.024
22. Pascart T, Ducoulombier V, Roquette D, Perimenis P, Coquerelle P, Maury F, et al.Autoimmune thyroid disorders during anti-TNF alpha therapy: coincidence, paradoxical event or marker of immunogenicity?Joint Bone Spine.2014;81:369-70 https://doi.org/10.1016/j.jbspin.2013.11.007
23. Peluso R, Lupoli GA, Del Puente A, Iervolino S, Bruner V, Lupoli R, et al. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol 2011;38:1371-7 https://doi.org/10.3899/jrheum.101012
24. Acay A, Ulu MS, Ahsen A, Eroglu S, Ozuguz U, Yuksel S, et al.Assessment of thyroid disorders and autoimmunity in patients with rheumatic diseases. Endocr Metab Immune Disord Drug Targets. 2014; 14:182-6 https://doi.org/10.2174/1871530314666140626113111
25. Emmungil H, Erdogan M, Kalfa M, Karabulut G, Kocanaogulları H, Inal V, et al.Autoimmune thyroid disease in ankylosing spondylitis.Clin Rheumatol. 2014;33:955-61 https://doi.org/10.1007/s10067-013-2466-1
26. Tarhan F, Orük G, Niflioğlu O, Ozer S.Thyroid involvement in ankylosing spondylitis and relationship of thyroid dysfunction with anti-TNF α treatment.Rheumatol Int.2013;33:853-7 https://doi.org/10.1007/s00296-012-2438-9
27. Zubelewicz B, Muc-Wierzgon M, Wierzgon J, Romanowski W, Mazurek U, Wilczok T, et al.Genetic dysregulation of gene coding tumor necrosis factor α receptors (TNF α Rs) in follicular thyroid cancer-preliminary report. Journal of Biological Regulators and Homeostatic Agents. 2002;16:98-104